A comprehensive, longitudinal analysis of humoral responses specific to four recombinant antigens of SARS-CoV-2 in severe and non-severe COVID-19 patients-Reference-Cited by-全球学者库

A comprehensive, longitudinal analysis of humoral responses specific to four recombinant antigens of SARS-CoV-2 in severe and non-severe COVID-19 patients

Published:2020-09-10 Issue:9 Volume:16 Page:e1008796
ISSN:1553-7374
Container-title:PLOS Pathogens
language:en
Short-container-title:PLoS Pathog

Author:

Chen Yuxin,Tong Xin,Li Yang,Gu Bin,Yan Jiawei,Liu Yong,Shen Han,Huang Rui^ORCID,Wu Chao^ORCID

Funder

Fundamental Research Funds for Central Universities of the Central South University

Publisher

Public Library of Science (PLoS)

Subject

Virology,Genetics,Molecular Biology,Immunology,Microbiology,Parasitology

Reference32 articles.

1. Organization WH. Coronavirus disease 2019 (COVID-19) situation Report-91. 2020.

2. Clinical Characteristics of Coronavirus Disease 2019 in China;WJ Guan;N Engl J Med,2020

3. Different longitudinal patterns of nucleic acid and serology testing results based on disease severity of COVID-19 patients;Z Yongchen;Emerg Microbes Infect,2020

4. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study;KK To;Lancet Infect Dis,2020

5. Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), March 2020.;RA Perera;Euro Surveill,2020

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A bead-based multiplex assay covering all coronaviruses pathogenic for humans for sensitive and specific surveillance of SARS-CoV-2 humoral immunity;Scientific Reports;2023-12-09

2. A Greater Increase in Complement C5a Receptor 1 Level at Onset and a Smaller Decrease in Immunoglobulin G Level after Recovery in Severer Coronavirus Disease 2019 Patients: A New Analysis of Existing Data with a New Two-Tailed t-Test;Biology;2023-08-28

3. Comparative Longitudinal Serological Study of Anti-SARS-CoV-2 Antibody Profiles in People with COVID-19;Microorganisms;2023-08-02

4. Development and validity assessment of ELISA test with recombinant chimeric protein of SARS-CoV-2;Journal of Immunological Methods;2023-08

5. Coronavac inactivated vaccine triggers durable, cross-reactive Fc-mediated phagocytosis activities;Emerging Microbes & Infections;2023-07-07